• Strong sales momentum: across the UK and Greece, the brands' first two markets.
  • Over $1.5 million in sales: C-Scrub and C-Sept have generated over $1.5 million in combined annualized sales across the United Kingdom and Greece.
  • High-margin proprietary pillar: gross margins above 70%, among the most attractive in Cosmos Health's portfolio.
  • EU expansion: targeting annual revenue rising to $7.4 million with gross profit of approximately $5.3 million within three years.
  • Potential upside: the target may be revised upward as C-Scrub launches into the animal healthcare market.